Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Hengan International Group Company Limited (HEGIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
5.00000.0000 (0.00%)
At close: 03:44PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.0000
Open5.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range5.0000 - 5.0000
52 Week Range4.9000 - 7.3800
Volume14,500
Avg. Volume3,634
Market Cap6.021B
Beta (5Y Monthly)0.39
PE Ratio (TTM)8.98
EPS (TTM)0.5570
Earnings DateN/A
Forward Dividend & Yield0.35 (7.10%)
Ex-Dividend DateSep 10, 2021
1y Target EstN/A
  • CNW Group

    IIROC Trading Resumption - PINK

    VANCOUVER, BC, March 1, 2021 /CNW/ - Trading resumes in: Company: Perimeter Medical Imaging AI, Inc.TSX-Venture Symbol: PINK All Issues: YesResumption (ET): 9:30 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.

  • CNW Group

    IIROC Trading Halt - PINK

    VANCOUVER, BC, March 1, 2021 /CNW/ - The following issues have been halted by IIROC: Company: Perimeter Medical Imaging AI, Inc.TSX-Venture Symbol: PINKAll Issues: YesReason: At the Request of the Company Pending NewsHalt Time (ET): 8:51 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.

  • Business Wire

    Perimeter Medical Imaging AI Announces U.S. FDA 510(k) Clearance for OCT Imaging System

    Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Perimeter’s Optical Coherence Tomography (OCT) Imaging System (v2.1), which is designed to examine tissue microstructures during surgical procedures by providing cross-sectional, real-time margin visualization.

Advertisement
Advertisement